Luoyang Third People's Hospital — Luoyang, He'nan

Public research footprint of Luoyang Third People's Hospital, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Overweight , Obesity · Heart Failure · T2DM (Type 2 Diabetes Mellitus) · Neovascular (Wet) Age-related Macular Degeneration

Recently updated registry entries

NCT06415773 — Effects of Berberine Ursodeoxycholate (HTD1801) Versus Dapagliflozin in Patients With… (Completed)
NCT07230119 — A Study of Zovaglutide in Subjects With Overweight or Obesity (HORIZON-1) (Active Not Recruiting)
NCT07064473 — EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Luoyang Third People's Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.